X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs SUVEN LIFE - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD SUVEN LIFE STRIDES SHASUN LTD/
SUVEN LIFE
 
P/E (TTM) x 13.2 19.2 68.7% View Chart
P/BV x 1.5 3.6 42.9% View Chart
Dividend Yield % 0.6 1.1 61.6%  

Financials

 STRIDES SHASUN LTD   SUVEN LIFE
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
SUVEN LIFE
Mar-16
STRIDES SHASUN LTD/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,275339 376.6%   
Low Rs918144 635.7%   
Sales per share (Unadj.) Rs389.639.2 992.6%  
Earnings per share (Unadj.) Rs28.07.5 374.8%  
Cash flow per share (Unadj.) Rs48.98.8 557.2%  
Dividends per share (Unadj.) Rs4.502.00 225.0%  
Dividend yield (eoy) %0.40.8 49.6%  
Book value per share (Unadj.) Rs303.149.0 618.6%  
Shares outstanding (eoy) m89.42127.28 70.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.86.2 45.7%   
Avg P/E ratio x39.232.4 121.1%  
P/CF ratio (eoy) x22.427.5 81.5%  
Price / Book Value ratio x3.64.9 73.4%  
Dividend payout %16.126.8 60.0%   
Avg Mkt Cap Rs m98,03630,732 319.0%   
No. of employees `0005.81.0 608.0%   
Total wages/salary Rs m5,881416 1,412.4%   
Avg. sales/employee Rs Th6,005.95,236.1 114.7%   
Avg. wages/employee Rs Th1,014.0436.5 232.3%   
Avg. net profit/employee Rs Th431.2995.5 43.3%   
INCOME DATA
Net Sales Rs m34,8344,995 697.4%  
Other income Rs m1,686194 871.2%   
Total revenues Rs m36,5205,189 703.8%   
Gross profit Rs m6,4281,233 521.5%  
Depreciation Rs m1,872167 1,119.3%   
Interest Rs m2,26954 4,186.9%   
Profit before tax Rs m3,9731,205 329.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470255 184.3%   
Profit after tax Rs m2,501950 263.3%  
Gross profit margin %18.524.7 74.8%  
Effective tax rate %11.821.2 55.9%   
Net profit margin %7.219.0 37.8%  
BALANCE SHEET DATA
Current assets Rs m38,1654,986 765.4%   
Current liabilities Rs m30,4021,042 2,917.0%   
Net working cap to sales %22.379.0 28.2%  
Current ratio x1.34.8 26.2%  
Inventory Days Days7761 126.8%  
Debtors Days Days10439 266.9%  
Net fixed assets Rs m37,6393,126 1,204.3%   
Share capital Rs m894127 702.4%   
"Free" reserves Rs m26,2103,717 705.1%   
Net worth Rs m27,1056,236 434.6%   
Long term debt Rs m16,377432 3,788.4%   
Total assets Rs m81,1688,079 1,004.7%  
Interest coverage x2.823.2 11.8%   
Debt to equity ratio x0.60.1 871.7%  
Sales to assets ratio x0.40.6 69.4%   
Return on assets %5.912.4 47.3%  
Return on equity %9.215.2 60.6%  
Return on capital %12.118.9 63.8%  
Exports to sales %087.5 0.0%   
Imports to sales %012.2 0.0%   
Exports (fob) Rs mNA4,371 0.0%   
Imports (cif) Rs mNA611 0.0%   
Fx inflow Rs m13,4654,666 288.6%   
Fx outflow Rs m4,076942 432.6%   
Net fx Rs m9,3893,724 252.1%   
CASH FLOW
From Operations Rs m2,881922 312.5%  
From Investments Rs m-7,051-619 1,138.6%  
From Financial Activity Rs m3,382-698 -484.3%  
Net Cashflow Rs m-788-396 199.0%  

Share Holding

Indian Promoters % 27.7 63.4 43.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 0.0 -  
FIIs % 8.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 36.5 71.0%  
Shareholders   56,241 37,287 150.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  PLETHICO PHARMA  FDC LTD.  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 23, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - ALKEM LABORATORIES COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS